1. Market Research
  2. > Biotechnology
  3. > Biological Therapy Market Trends
  4. > PharmaSphere: Emerging Biotechnologies - Antisense RNAi Therapeutics Market Analysis

PharmaSphere: Emerging Biotechnologies - Antisense RNAi Therapeutics Market Analysis

  • September 2015
  • -
  • GlobalData
  • -
  • 124 pages

Summary

Table of Contents

Search Inside

PharmaSphere: Emerging Biotechnologies - Antisense RNAi Therapeutics Market Analysis

Summary

GlobalData’s "PharmaSphere: Emerging Biotechnologies - Antisense RNAi Therapeutics Market Analysis" report is an essential source of information and analysis on the RNA interference (RNAi) therapy field. Using detailed company data, deal analysis, corporate strategy, and market trends, GlobalData provides an in-depth analysis of the current and future growth drivers of the RNAi therapy market. The report discusses the key factors shaping and driving the RNAi therapy business, and provides insights into the competitive landscape and emerging strategies expected to significantly influence the market positions of companies currently involved in the development and commercialization of RNAi therapeutics.

Highlights

Key Questions Answered

- What are the drivers of the RNAi therapy field?
- Who are the leading companies involved in the development of RNAi therapies?
- What are the major trends in RNAi clinical trials?
- What specific therapeutic areas and indications are receiving the most clinical research?
- What specific business development activities are taking place in terms of partnerships or mergers and acquisitions (M&As)?
- Has investor confidence been restored in the antisense/RNAi therapy field?

Scope

- This report provides market developments across the RNAi therapy field, including clinical trials, deals, and pipeline investments
- Investment examined from both industry and financial communities
- Clinical trials activity examined across phase of development, therapy area, and indication.
- This report offers a deep dive into the synergies behind partnering and acquisition activities
- Deals examined across geography, entity type, company, financial advisor, phase of development, therapy area, indication, and mechanism of action
- Pipeline profiles of 25 leading biotech companies developing RNAi therapeutics

Reasons to buy

- Identify the key players in the RNAi market.
- Analyze and track the strategies that companies are using to strengthen their position in the RNAi therapy field; independent source for due diligence.
- Organize your sales and marketing strategy to identify companies with proprietary technologies in order to maximize opportunities for licensing, partnership, investment, or takeover.
- Understand the flow of investment from capital markets into the RNAi therapy field.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Autologous Cell Therapy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Autologous Cell Therapy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • January 2017
  • by Transparency Market Research

Global Autologous Cell Therapy Market: Overview This report provides in-depth region wise and country wise analysis of the autologous cell therapy market. Stakeholders of this report include manufacturers ...

Regenerative Medicine Market by Therapy, Product, Applications - Forecast to 2021

Regenerative Medicine Market by Therapy, Product, Applications - Forecast to 2021

  • $ 5650
  • Industry report
  • February 2017
  • by MarketsandMarkets

“Regenerative Medicine Market by Therapy (Cell Therapy, Tissue Engineering, Immunotherapy, Gene Therapy), By Product (Cell-Based, Acellular), By Applications (Orthopedic & Musculoskeletal Disorders, ...

Top 10 Bioprocess Technology Market by Cell Culture, Cell Expansion, Cell Counting, Cell Line Development, Flow Cytometry, Single-Use Bioprocessing, Biologics Safety Testing, Tangential Flow Filtration, Virus Filtration & Region - Forecast to 2021

Top 10 Bioprocess Technology Market by Cell Culture, Cell Expansion, Cell Counting, Cell Line Development, Flow Cytometry, Single-Use Bioprocessing, Biologics Safety Testing, Tangential Flow Filtration, Virus Filtration & Region - Forecast to 2021

  • $ 5650
  • Industry report
  • January 2017
  • by MarketsandMarkets

The global top 10 bioprocess technology market is expected to reach USD 71.03 billion by 2021 from USD 39.30 billion in 2016, at a CAGR of 12.4% from 2016 to 2021. On the basis of type, the market is segmented ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.